SPONSOR
InSightec
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Opioid-use DisorderSubstance Use DisordersAlzheimer DiseaseMovement DisordersNeurologyParkinsons Disease
InSightec is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Opioid-use Disorder, Substance Use Disorders, Alzheimer Disease, Movement Disorders.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — InSightec
How many clinical trials has InSightec sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by InSightec, of which 3 are actively recruiting participants. These trials cover conditions including Opioid-use Disorder, Substance Use Disorders, Alzheimer Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does InSightec research focus on?
InSightec clinical trials span Opioid-use Disorder, Substance Use Disorders, Alzheimer Disease, Movement Disorders, Neurology, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a InSightec clinical trial?
To participate in a InSightec trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all InSightec trials with current recruitment status updated daily.
Clinical Trials by InSightec
NCT04197921
Recruiting
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
Opioid-use Disorder
NCT03671889
Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Alzheimer Disease
NCT05539196
Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Movement Disorders
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology